Prophylaxis of cytomegalovirus infection in renal transplantation

被引：14

作者：

Kuypers, DRJ ^{[1
]}

Vanrenterghem, Y ^{[1
]}

机构：

[1] Univ Ziekenhuizen Leuven, Dept Nephrol & Renal Transplantat, B-3000 Louvain, Belgium

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1998年 / 13卷 / 12期

关键词：

cytomegalovirus; diagnosis; ganciclovir; prophylaxis; renal transplantation; pre-emptive/deferred therapy;

D O I：

10.1093/ndt/13.12.3012

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：3012 / 3016

页数：5

共 12 条

[1] A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].

BALFOUR, HH ;

CHACE, BA ;

STAPLETON, JT ;

SIMMONS, RL ;

FRYD, DS .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) :1381-1387

[2] Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients [J].

Brennan, DC ;

Garlock, KA ;

Singer, GG ;

Schnitzler, MA ;

Lippmann, BJ ;

Buller, RS ;

Gaudreault-Keener, M ;

Lowell, JA ;

Shenoy, S ;

Howard, TK ;

Storch, GA .

TRANSPLANTATION, 1997, 64 (12) :1843-1846

[3]

Brennan DC, 1997, J AM SOC NEPHROL, V8, P118

[4] Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment [J].

Craigen, JL ;

Grundy, JE .

TRANSPLANTATION, 1996, 62 (08) :1102-1108

[5] Studies evaluating high-dose acyclovir, intravenous immune globulin, and cytomegalovirus hyperimmunoglobulin for prophylaxis against cytomegalovirus in kidney transplant recipients [J].

Dickinson, BI ;

GoraHarper, ML ;

McCraney, SA ;

Gosland, M .

ANNALS OF PHARMACOTHERAPY, 1996, 30 (12) :1452-1464

[6]

FLECHNER SM, 1998, 17 ANN M AM SOC TRAN, V739, P263

[7]

Gotti E, 1996, CLIN TRANSPLANT, V10, P550

[8]

Lo CY, 1997, CLIN TRANSPLANT, V11, P286

[9]

LOWANCE D, 1998, 17 ANN M AM SOC TRAN, V61, P94

[10]

Neyts J, 1998, ANTIMICROB AGENTS CH, V42, P216

← 1 2 →